John Rinn
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Long Noncoding | 61 | 2023 | 161 | 18.190 |
Why?
| RNA, Untranslated | 27 | 2021 | 115 | 6.790 |
Why?
| Gene Expression Regulation | 48 | 2021 | 2445 | 4.810 |
Why?
| Chromatin | 26 | 2023 | 441 | 4.370 |
Why?
| RNA | 16 | 2022 | 833 | 3.040 |
Why?
| Cell Nucleus | 13 | 2023 | 580 | 2.670 |
Why?
| Genome | 12 | 2022 | 277 | 2.540 |
Why?
| Genome, Human | 18 | 2021 | 387 | 2.450 |
Why?
| Enhancer Elements, Genetic | 10 | 2020 | 152 | 2.220 |
Why?
| RNA, Messenger | 25 | 2021 | 2657 | 2.220 |
Why?
| Promoter Regions, Genetic | 16 | 2021 | 1158 | 2.170 |
Why?
| Tumor Suppressor Protein p53 | 8 | 2017 | 455 | 2.100 |
Why?
| Transcription, Genetic | 28 | 2020 | 1323 | 2.090 |
Why?
| RNA-Binding Proteins | 14 | 2020 | 371 | 1.950 |
Why?
| Repetitive Sequences, Nucleic Acid | 3 | 2021 | 103 | 1.860 |
Why?
| Models, Genetic | 8 | 2018 | 595 | 1.780 |
Why?
| Epigenesis, Genetic | 16 | 2021 | 539 | 1.760 |
Why?
| Sequence Analysis, RNA | 14 | 2019 | 409 | 1.580 |
Why?
| Cell Differentiation | 25 | 2023 | 1753 | 1.560 |
Why?
| Telomerase | 3 | 2021 | 207 | 1.470 |
Why?
| Gene Deletion | 6 | 2021 | 361 | 1.470 |
Why?
| Transcriptome | 11 | 2020 | 756 | 1.440 |
Why?
| Animals | 90 | 2023 | 33381 | 1.420 |
Why?
| Fibroblasts | 10 | 2018 | 842 | 1.370 |
Why?
| CCCTC-Binding Factor | 2 | 2018 | 12 | 1.320 |
Why?
| Genomics | 13 | 2022 | 706 | 1.250 |
Why?
| Base Sequence | 18 | 2020 | 2159 | 1.250 |
Why?
| Mice | 58 | 2022 | 15520 | 1.240 |
Why?
| X Chromosome Inactivation | 5 | 2020 | 21 | 1.230 |
Why?
| Chromosomes | 3 | 2018 | 87 | 1.210 |
Why?
| DNA, Complementary | 8 | 2020 | 268 | 1.190 |
Why?
| Embryonic Stem Cells | 10 | 2015 | 114 | 1.160 |
Why?
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 25 | 1.150 |
Why?
| Genetic Loci | 7 | 2020 | 281 | 1.140 |
Why?
| Gene Expression Regulation, Developmental | 16 | 2023 | 814 | 1.050 |
Why?
| Transcription Factors | 17 | 2020 | 1570 | 1.020 |
Why?
| Molecular Sequence Annotation | 7 | 2020 | 91 | 1.010 |
Why?
| Open Reading Frames | 7 | 2020 | 121 | 1.010 |
Why?
| Gene Expression Profiling | 29 | 2020 | 1597 | 0.990 |
Why?
| Hematopoiesis | 3 | 2021 | 175 | 0.980 |
Why?
| DNA Damage | 2 | 2017 | 357 | 0.950 |
Why?
| Induced Pluripotent Stem Cells | 7 | 2021 | 185 | 0.950 |
Why?
| Humans | 117 | 2023 | 118974 | 0.930 |
Why?
| Mice, Knockout | 13 | 2020 | 2680 | 0.910 |
Why?
| RNA Splicing | 6 | 2021 | 243 | 0.870 |
Why?
| Fertility | 2 | 2020 | 135 | 0.870 |
Why?
| Microscopy, Confocal | 3 | 2018 | 314 | 0.850 |
Why?
| Pluripotent Stem Cells | 6 | 2022 | 65 | 0.850 |
Why?
| Regulatory Elements, Transcriptional | 4 | 2020 | 18 | 0.830 |
Why?
| Computational Biology | 7 | 2021 | 588 | 0.830 |
Why?
| Polycomb Repressive Complex 2 | 5 | 2020 | 60 | 0.800 |
Why?
| Ebolavirus | 4 | 2023 | 34 | 0.790 |
Why?
| Hemorrhagic Fever, Ebola | 4 | 2023 | 34 | 0.790 |
Why?
| Binding Sites | 12 | 2020 | 1224 | 0.780 |
Why?
| Cellular Reprogramming | 4 | 2018 | 85 | 0.770 |
Why?
| Cytoplasm | 3 | 2022 | 269 | 0.760 |
Why?
| Evolution, Molecular | 4 | 2020 | 454 | 0.750 |
Why?
| Sequence Deletion | 3 | 2020 | 171 | 0.750 |
Why?
| Cell Line | 16 | 2021 | 2707 | 0.750 |
Why?
| Body Patterning | 4 | 2008 | 131 | 0.740 |
Why?
| DNA | 7 | 2022 | 1388 | 0.730 |
Why?
| K562 Cells | 5 | 2021 | 73 | 0.710 |
Why?
| Repressor Proteins | 7 | 2018 | 377 | 0.700 |
Why?
| Embryonic Development | 6 | 2019 | 118 | 0.700 |
Why?
| DNA-Binding Proteins | 7 | 2021 | 1346 | 0.690 |
Why?
| Polymorphism, Single Nucleotide | 6 | 2020 | 2062 | 0.690 |
Why?
| In Situ Hybridization, Fluorescence | 7 | 2021 | 310 | 0.680 |
Why?
| Oligonucleotide Array Sequence Analysis | 17 | 2016 | 770 | 0.670 |
Why?
| Nucleic Acid Conformation | 6 | 2022 | 670 | 0.670 |
Why?
| Organ Specificity | 6 | 2019 | 278 | 0.660 |
Why?
| Endogenous Retroviruses | 2 | 2022 | 19 | 0.650 |
Why?
| DNA Methylation | 8 | 2022 | 503 | 0.650 |
Why?
| Alleles | 5 | 2020 | 832 | 0.640 |
Why?
| Sequence Analysis, DNA | 3 | 2016 | 755 | 0.640 |
Why?
| Time-Lapse Imaging | 1 | 2018 | 19 | 0.640 |
Why?
| Protein Biosynthesis | 1 | 2020 | 397 | 0.640 |
Why?
| Chromosomes, Human | 1 | 2018 | 41 | 0.640 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 58 | 0.640 |
Why?
| Chromosome Aberrations | 1 | 2018 | 136 | 0.640 |
Why?
| Molecular Sequence Data | 10 | 2015 | 2871 | 0.630 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 1167 | 0.610 |
Why?
| Gene Regulatory Networks | 7 | 2018 | 239 | 0.570 |
Why?
| High-Throughput Nucleotide Sequencing | 6 | 2018 | 453 | 0.570 |
Why?
| Neoplasms | 5 | 2019 | 2179 | 0.560 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 109 | 0.560 |
Why?
| Homeodomain Proteins | 6 | 2013 | 468 | 0.550 |
Why?
| Ribonucleoproteins | 3 | 2012 | 88 | 0.550 |
Why?
| DNA, Satellite | 1 | 2015 | 17 | 0.550 |
Why?
| DNA, Intergenic | 4 | 2011 | 25 | 0.540 |
Why?
| Centromere | 1 | 2015 | 43 | 0.530 |
Why?
| Plasmodium falciparum | 2 | 2015 | 34 | 0.530 |
Why?
| Genes, Homeobox | 5 | 2013 | 51 | 0.530 |
Why?
| DNA Transposable Elements | 1 | 2014 | 102 | 0.490 |
Why?
| Nuclear Proteins | 3 | 2016 | 597 | 0.480 |
Why?
| Systems Biology | 3 | 2011 | 57 | 0.470 |
Why?
| HeLa Cells | 8 | 2021 | 583 | 0.460 |
Why?
| Myoblasts | 3 | 2022 | 75 | 0.460 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 115 | 0.460 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2014 | 138 | 0.450 |
Why?
| Retroelements | 1 | 2012 | 34 | 0.440 |
Why?
| Protein Binding | 11 | 2020 | 1975 | 0.440 |
Why?
| RNA Interference | 7 | 2021 | 460 | 0.440 |
Why?
| HEK293 Cells | 7 | 2021 | 625 | 0.440 |
Why?
| Adipogenesis | 1 | 2013 | 47 | 0.440 |
Why?
| Homeostasis | 4 | 2021 | 594 | 0.440 |
Why?
| Skin | 2 | 2008 | 657 | 0.430 |
Why?
| Brain | 2 | 2015 | 2490 | 0.430 |
Why?
| Phenotype | 7 | 2021 | 3003 | 0.430 |
Why?
| Cells, Cultured | 16 | 2021 | 4077 | 0.420 |
Why?
| Epidermis | 2 | 2012 | 152 | 0.400 |
Why?
| RNA Stability | 5 | 2021 | 97 | 0.400 |
Why?
| Introns | 5 | 2021 | 234 | 0.400 |
Why?
| Human Embryonic Stem Cells | 2 | 2021 | 19 | 0.400 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 2023 | 80 | 0.390 |
Why?
| Histones | 11 | 2021 | 552 | 0.380 |
Why?
| Single-Cell Analysis | 5 | 2020 | 187 | 0.380 |
Why?
| Telomere | 2 | 2019 | 204 | 0.380 |
Why?
| Conserved Sequence | 6 | 2020 | 219 | 0.380 |
Why?
| Mouse Embryonic Stem Cells | 3 | 2020 | 25 | 0.370 |
Why?
| Down-Regulation | 3 | 2016 | 627 | 0.360 |
Why?
| Muscle Development | 3 | 2022 | 102 | 0.360 |
Why?
| Chromosomes, Human, Pair 22 | 4 | 2004 | 39 | 0.360 |
Why?
| Sex Characteristics | 2 | 2005 | 671 | 0.360 |
Why?
| Gene Library | 4 | 2018 | 127 | 0.350 |
Why?
| Gene Editing | 2 | 2021 | 63 | 0.350 |
Why?
| CRISPR-Cas Systems | 3 | 2021 | 85 | 0.350 |
Why?
| MicroRNAs | 8 | 2021 | 637 | 0.340 |
Why?
| Mammals | 5 | 2021 | 253 | 0.330 |
Why?
| Nucleotide Motifs | 3 | 2017 | 31 | 0.330 |
Why?
| Antineoplastic Agents | 1 | 2019 | 1974 | 0.320 |
Why?
| Immunity, Innate | 3 | 2019 | 745 | 0.320 |
Why?
| Cell Lineage | 5 | 2021 | 318 | 0.310 |
Why?
| Lymphopoiesis | 2 | 2021 | 23 | 0.310 |
Why?
| Chromatin Assembly and Disassembly | 5 | 2017 | 93 | 0.310 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 27 | 0.300 |
Why?
| Colorectal Neoplasms | 1 | 2014 | 628 | 0.300 |
Why?
| Genomic Imprinting | 2 | 2021 | 32 | 0.300 |
Why?
| Wnt Proteins | 1 | 2008 | 140 | 0.290 |
Why?
| Proteins | 6 | 2018 | 938 | 0.290 |
Why?
| Reproducibility of Results | 6 | 2021 | 2874 | 0.290 |
Why?
| DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 13 | 0.290 |
Why?
| HCT116 Cells | 3 | 2021 | 68 | 0.270 |
Why?
| MAP Kinase Signaling System | 1 | 2007 | 292 | 0.270 |
Why?
| Exons | 4 | 2016 | 307 | 0.270 |
Why?
| Male | 20 | 2020 | 57801 | 0.260 |
Why?
| Databases, Genetic | 4 | 2020 | 253 | 0.260 |
Why?
| Myosin Heavy Chains | 2 | 2021 | 192 | 0.250 |
Why?
| Signal Transduction | 11 | 2021 | 4709 | 0.250 |
Why?
| Genitalia | 1 | 2004 | 27 | 0.250 |
Why?
| Motor Neurons | 3 | 2015 | 213 | 0.250 |
Why?
| Drug Resistance, Neoplasm | 2 | 2019 | 671 | 0.240 |
Why?
| Proto-Oncogene Proteins | 1 | 2008 | 618 | 0.240 |
Why?
| Gene Knockdown Techniques | 4 | 2013 | 311 | 0.240 |
Why?
| Hemorrhagic Fevers, Viral | 1 | 2023 | 3 | 0.240 |
Why?
| Alternative Splicing | 2 | 2018 | 193 | 0.230 |
Why?
| Female | 22 | 2023 | 61565 | 0.230 |
Why?
| Zebrafish | 4 | 2013 | 434 | 0.230 |
Why?
| Cluster Analysis | 5 | 2015 | 481 | 0.220 |
Why?
| Databases, Nucleic Acid | 2 | 2021 | 36 | 0.220 |
Why?
| Plasmids | 1 | 2023 | 355 | 0.220 |
Why?
| Mitosis | 2 | 2021 | 172 | 0.210 |
Why?
| NF-kappa B | 4 | 2020 | 670 | 0.210 |
Why?
| X Chromosome | 2 | 2020 | 47 | 0.210 |
Why?
| Pharmaceutical Preparations | 1 | 2004 | 167 | 0.210 |
Why?
| RNA Transport | 3 | 2016 | 22 | 0.210 |
Why?
| Ribonucleases | 2 | 2019 | 53 | 0.210 |
Why?
| Genetic Techniques | 2 | 2013 | 60 | 0.200 |
Why?
| Gene Targeting | 1 | 2021 | 80 | 0.200 |
Why?
| Ectoderm | 1 | 2021 | 43 | 0.200 |
Why?
| Mice, Inbred Strains | 2 | 2019 | 405 | 0.200 |
Why?
| Cell Compartmentation | 1 | 2021 | 53 | 0.200 |
Why?
| Research Report | 1 | 2021 | 75 | 0.200 |
Why?
| Muscle Fibers, Skeletal | 2 | 2022 | 192 | 0.200 |
Why?
| Genetic Association Studies | 3 | 2014 | 371 | 0.200 |
Why?
| Ikaros Transcription Factor | 1 | 2021 | 17 | 0.200 |
Why?
| Cardiac Myosins | 1 | 2021 | 33 | 0.190 |
Why?
| Stem Cells | 3 | 2022 | 559 | 0.190 |
Why?
| Receptor, Insulin | 1 | 2021 | 100 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 982 | 0.190 |
Why?
| Placenta | 3 | 2021 | 639 | 0.190 |
Why?
| Spermatogenesis | 1 | 2020 | 53 | 0.190 |
Why?
| Protein Domains | 2 | 2020 | 212 | 0.190 |
Why?
| Epigenomics | 2 | 2011 | 107 | 0.190 |
Why?
| Lipopolysaccharides | 3 | 2019 | 870 | 0.190 |
Why?
| Telomere Homeostasis | 1 | 2020 | 24 | 0.190 |
Why?
| Eukaryotic Cells | 1 | 2020 | 34 | 0.190 |
Why?
| Polycomb-Group Proteins | 3 | 2010 | 36 | 0.190 |
Why?
| RNA Precursors | 1 | 2021 | 136 | 0.180 |
Why?
| Congresses as Topic | 1 | 2021 | 204 | 0.180 |
Why?
| Preimplantation Diagnosis | 1 | 2019 | 4 | 0.180 |
Why?
| Species Specificity | 1 | 2021 | 565 | 0.180 |
Why?
| Dactinomycin | 1 | 2019 | 24 | 0.180 |
Why?
| SOXB1 Transcription Factors | 1 | 2020 | 61 | 0.180 |
Why?
| Embryo Implantation | 1 | 2019 | 24 | 0.180 |
Why?
| Genome-Wide Association Study | 4 | 2020 | 1323 | 0.180 |
Why?
| RNA Processing, Post-Transcriptional | 3 | 2018 | 84 | 0.180 |
Why?
| Drug Tolerance | 1 | 2019 | 78 | 0.180 |
Why?
| Cell Line, Tumor | 4 | 2021 | 2851 | 0.170 |
Why?
| Fertilization in Vitro | 1 | 2019 | 73 | 0.170 |
Why?
| Organelles | 2 | 2017 | 55 | 0.170 |
Why?
| RNA, Fungal | 2 | 2010 | 66 | 0.170 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 522 | 0.170 |
Why?
| Protein Conformation | 2 | 2021 | 848 | 0.170 |
Why?
| Pattern Recognition, Automated | 1 | 2019 | 76 | 0.170 |
Why?
| Transgenes | 3 | 2020 | 174 | 0.170 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2018 | 28 | 0.170 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2018 | 28 | 0.160 |
Why?
| Cell Proliferation | 7 | 2020 | 2275 | 0.160 |
Why?
| Apoptosis | 4 | 2018 | 2484 | 0.160 |
Why?
| Binding, Competitive | 2 | 2020 | 205 | 0.160 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2018 | 63 | 0.160 |
Why?
| Adipocytes | 1 | 2020 | 199 | 0.160 |
Why?
| HMGA2 Protein | 1 | 2018 | 8 | 0.160 |
Why?
| Cell Nucleolus | 1 | 2018 | 17 | 0.160 |
Why?
| Lymphocytes | 2 | 2017 | 347 | 0.160 |
Why?
| Molecular Imaging | 1 | 2018 | 54 | 0.160 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 290 | 0.160 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 226 | 0.160 |
Why?
| Macaca mulatta | 3 | 2023 | 153 | 0.160 |
Why?
| Cyclooxygenase 2 | 1 | 2018 | 168 | 0.160 |
Why?
| Cell Transformation, Neoplastic | 2 | 2017 | 317 | 0.160 |
Why?
| Translocation, Genetic | 1 | 2018 | 92 | 0.160 |
Why?
| Immunity | 1 | 2018 | 129 | 0.160 |
Why?
| Pyramidal Tracts | 2 | 2014 | 20 | 0.160 |
Why?
| Consensus Sequence | 2 | 2016 | 70 | 0.160 |
Why?
| Bone Morphogenetic Proteins | 1 | 2018 | 137 | 0.160 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 300 | 0.160 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 60 | 0.160 |
Why?
| Mice, Inbred C57BL | 9 | 2020 | 4908 | 0.150 |
Why?
| High-Throughput Screening Assays | 2 | 2016 | 122 | 0.150 |
Why?
| Staining and Labeling | 1 | 2017 | 146 | 0.150 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 280 | 0.150 |
Why?
| Splicing Factor U2AF | 1 | 2016 | 16 | 0.150 |
Why?
| Genetic Testing | 1 | 2019 | 389 | 0.150 |
Why?
| Bcl-2-Like Protein 11 | 1 | 2016 | 38 | 0.150 |
Why?
| Kidney | 1 | 2004 | 1353 | 0.140 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 80 | 0.140 |
Why?
| Histone Deacetylases | 1 | 2018 | 198 | 0.140 |
Why?
| HLA-G Antigens | 1 | 2016 | 1 | 0.140 |
Why?
| Histocompatibility, Maternal-Fetal | 1 | 2016 | 3 | 0.140 |
Why?
| Support Vector Machine | 1 | 2016 | 36 | 0.140 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2016 | 8 | 0.140 |
Why?
| Mutation | 5 | 2018 | 3457 | 0.140 |
Why?
| Image Processing, Computer-Assisted | 2 | 2018 | 709 | 0.140 |
Why?
| Genotype | 1 | 2021 | 1882 | 0.140 |
Why?
| Doxorubicin | 1 | 2017 | 302 | 0.140 |
Why?
| Chromatin Assembly Factor-1 | 1 | 2015 | 9 | 0.140 |
Why?
| Active Transport, Cell Nucleus | 1 | 2016 | 113 | 0.140 |
Why?
| PTEN Phosphohydrolase | 2 | 2016 | 143 | 0.140 |
Why?
| Liver | 1 | 2004 | 1816 | 0.140 |
Why?
| Methylation | 5 | 2020 | 204 | 0.140 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 18 | 0.140 |
Why?
| Nervous System | 1 | 2015 | 66 | 0.130 |
Why?
| Myocardium | 1 | 2021 | 970 | 0.130 |
Why?
| rho GTP-Binding Proteins | 1 | 2016 | 65 | 0.130 |
Why?
| Muscular Atrophy, Spinal | 1 | 2015 | 18 | 0.130 |
Why?
| Linkage Disequilibrium | 1 | 2016 | 273 | 0.130 |
Why?
| Chondrocytes | 1 | 2018 | 206 | 0.130 |
Why?
| Pseudogenes | 2 | 2014 | 20 | 0.130 |
Why?
| Erythrocytes | 1 | 2020 | 641 | 0.130 |
Why?
| beta-Galactosidase | 1 | 2015 | 65 | 0.130 |
Why?
| Myeloid Cells | 1 | 2016 | 128 | 0.130 |
Why?
| Immunohistochemistry | 3 | 2015 | 1691 | 0.130 |
Why?
| RNA, Protozoan | 1 | 2015 | 58 | 0.130 |
Why?
| Genes | 1 | 2015 | 231 | 0.130 |
Why?
| Gene Silencing | 2 | 2013 | 177 | 0.130 |
Why?
| Maternal-Fetal Exchange | 1 | 2016 | 157 | 0.130 |
Why?
| Gene Expression | 4 | 2015 | 1489 | 0.130 |
Why?
| STAT3 Transcription Factor | 1 | 2016 | 189 | 0.130 |
Why?
| Lysine | 3 | 2020 | 248 | 0.130 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 97 | 0.130 |
Why?
| Neurons | 2 | 2021 | 1345 | 0.130 |
Why?
| Hematopoietic Stem Cells | 1 | 2018 | 359 | 0.130 |
Why?
| Pyramidal Cells | 1 | 2014 | 54 | 0.130 |
Why?
| Neocortex | 1 | 2014 | 25 | 0.130 |
Why?
| RNA, Catalytic | 1 | 2015 | 182 | 0.130 |
Why?
| Pregnancy | 4 | 2023 | 5691 | 0.130 |
Why?
| Molecular Biology | 1 | 2015 | 58 | 0.120 |
Why?
| Protein-Tyrosine Kinases | 1 | 2018 | 407 | 0.120 |
Why?
| Leukemia, Myeloid, Acute | 2 | 2018 | 532 | 0.120 |
Why?
| Kinetics | 1 | 2018 | 1624 | 0.120 |
Why?
| Trophoblasts | 1 | 2016 | 170 | 0.120 |
Why?
| Protein Footprinting | 1 | 2014 | 9 | 0.120 |
Why?
| Neurotransmitter Agents | 1 | 2014 | 76 | 0.120 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2020 | 984 | 0.120 |
Why?
| Keratinocytes | 2 | 2012 | 227 | 0.120 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 34 | 0.120 |
Why?
| Neuronal Plasticity | 1 | 2015 | 219 | 0.120 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 509 | 0.120 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2011 | 155 | 0.120 |
Why?
| Immunoprecipitation | 1 | 2014 | 161 | 0.120 |
Why?
| Information Theory | 1 | 2013 | 4 | 0.110 |
Why?
| Nerve Tissue Proteins | 2 | 2014 | 551 | 0.110 |
Why?
| Fetus | 1 | 2017 | 690 | 0.110 |
Why?
| Ubiquitination | 1 | 2013 | 87 | 0.110 |
Why?
| Natural Killer T-Cells | 1 | 2013 | 62 | 0.110 |
Why?
| Nervous System Diseases | 1 | 2015 | 261 | 0.110 |
Why?
| Protein Array Analysis | 1 | 2012 | 63 | 0.110 |
Why?
| Registries | 1 | 2020 | 1810 | 0.110 |
Why?
| Adipocytes, Brown | 1 | 2012 | 6 | 0.110 |
Why?
| Ribosomes | 1 | 2013 | 142 | 0.110 |
Why?
| Mice, Transgenic | 5 | 2020 | 2025 | 0.110 |
Why?
| Adipocytes, White | 1 | 2012 | 17 | 0.110 |
Why?
| Genes, Overlapping | 1 | 2011 | 2 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1715 | 0.100 |
Why?
| Genome, Protozoan | 1 | 2011 | 3 | 0.100 |
Why?
| Genes, Protozoan | 1 | 2011 | 11 | 0.100 |
Why?
| Biological Evolution | 1 | 2015 | 443 | 0.100 |
Why?
| Mitochondria | 2 | 2020 | 786 | 0.100 |
Why?
| Disease | 1 | 2012 | 98 | 0.100 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.100 |
Why?
| Artifacts | 1 | 2011 | 125 | 0.100 |
Why?
| Sequence Alignment | 1 | 2011 | 336 | 0.090 |
Why?
| Colonic Neoplasms | 1 | 2013 | 224 | 0.090 |
Why?
| Insulin | 2 | 2018 | 2162 | 0.090 |
Why?
| Argonaute Proteins | 3 | 2016 | 28 | 0.090 |
Why?
| Sexual Maturation | 1 | 2010 | 51 | 0.090 |
Why?
| Octamer Transcription Factor-3 | 2 | 2021 | 16 | 0.090 |
Why?
| Body Size | 1 | 2010 | 94 | 0.090 |
Why?
| Adenocarcinoma | 1 | 2016 | 812 | 0.090 |
Why?
| Saccharomyces cerevisiae | 2 | 2010 | 495 | 0.090 |
Why?
| Thymus Gland | 2 | 2008 | 300 | 0.090 |
Why?
| Proteome | 1 | 2012 | 353 | 0.090 |
Why?
| Zebrafish Proteins | 2 | 2010 | 252 | 0.080 |
Why?
| Prostatic Neoplasms | 1 | 2016 | 940 | 0.080 |
Why?
| Chromosome Mapping | 3 | 2004 | 510 | 0.080 |
Why?
| Drosophila melanogaster | 1 | 2010 | 200 | 0.080 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.080 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 64 | 0.080 |
Why?
| Viruses | 1 | 2009 | 96 | 0.080 |
Why?
| Wnt-5a Protein | 1 | 2008 | 19 | 0.080 |
Why?
| Bone Marrow Cells | 1 | 2009 | 273 | 0.080 |
Why?
| Myosin Type V | 1 | 2008 | 9 | 0.080 |
Why?
| Chromosome Disorders | 1 | 2008 | 39 | 0.080 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 544 | 0.080 |
Why?
| Keratins | 1 | 2008 | 174 | 0.080 |
Why?
| Software | 1 | 2012 | 613 | 0.080 |
Why?
| Genes, Reporter | 2 | 2020 | 270 | 0.080 |
Why?
| Amino Acid Sequence | 2 | 2020 | 2071 | 0.080 |
Why?
| Autoantigens | 2 | 2008 | 397 | 0.080 |
Why?
| Cell Survival | 3 | 2016 | 1047 | 0.080 |
Why?
| Zinc Fingers | 1 | 2007 | 46 | 0.080 |
Why?
| Peptides | 1 | 2012 | 879 | 0.070 |
Why?
| Retinol-Binding Proteins | 1 | 2006 | 13 | 0.070 |
Why?
| Wound Healing | 1 | 2009 | 270 | 0.070 |
Why?
| Bacteria | 2 | 2013 | 757 | 0.070 |
Why?
| Breast Neoplasms | 2 | 2016 | 1965 | 0.070 |
Why?
| Epithelium | 1 | 2008 | 305 | 0.070 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 160 | 0.070 |
Why?
| Protozoan Proteins | 1 | 2007 | 67 | 0.070 |
Why?
| ras Proteins | 1 | 2007 | 141 | 0.070 |
Why?
| Eye Proteins | 1 | 2006 | 77 | 0.070 |
Why?
| Algorithms | 1 | 2014 | 1541 | 0.070 |
Why?
| Dendritic Cells | 1 | 2009 | 442 | 0.070 |
Why?
| Monocytes | 2 | 2020 | 513 | 0.070 |
Why?
| Tissue Distribution | 1 | 2006 | 334 | 0.070 |
Why?
| RNA, Small Interfering | 2 | 2021 | 564 | 0.070 |
Why?
| Up-Regulation | 2 | 2020 | 872 | 0.070 |
Why?
| Quantitative Trait Loci | 2 | 2020 | 324 | 0.070 |
Why?
| Neoplastic Stem Cells | 1 | 2009 | 336 | 0.070 |
Why?
| RNA Polymerase II | 2 | 2023 | 282 | 0.060 |
Why?
| Transcortin | 1 | 2004 | 20 | 0.060 |
Why?
| Serpins | 1 | 2004 | 26 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 348 | 0.060 |
Why?
| Metabolic Clearance Rate | 1 | 2004 | 113 | 0.060 |
Why?
| Testis | 1 | 2004 | 144 | 0.060 |
Why?
| Virus Internalization | 1 | 2023 | 41 | 0.060 |
Why?
| Hypothalamus | 1 | 2004 | 155 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 144 | 0.060 |
Why?
| SOXF Transcription Factors | 1 | 2023 | 18 | 0.060 |
Why?
| Autoimmune Diseases | 1 | 2006 | 398 | 0.060 |
Why?
| Endoderm | 1 | 2023 | 19 | 0.060 |
Why?
| Selection, Genetic | 1 | 2005 | 252 | 0.060 |
Why?
| Chromatin Immunoprecipitation | 2 | 2016 | 136 | 0.060 |
Why?
| Poly A | 1 | 2003 | 47 | 0.060 |
Why?
| Ovary | 1 | 2004 | 205 | 0.050 |
Why?
| Macrophages | 2 | 2020 | 1324 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2016 | 462 | 0.050 |
Why?
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.050 |
Why?
| Models, Statistical | 1 | 2006 | 636 | 0.050 |
Why?
| Receptors, Cell Surface | 1 | 2004 | 367 | 0.050 |
Why?
| Cytoskeletal Proteins | 2 | 2012 | 146 | 0.050 |
Why?
| Histone Demethylases | 2 | 2015 | 28 | 0.050 |
Why?
| RNA, Small Untranslated | 1 | 2021 | 15 | 0.050 |
Why?
| Disease Models, Animal | 4 | 2017 | 3730 | 0.050 |
Why?
| Time Factors | 3 | 2020 | 6412 | 0.050 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2023 | 176 | 0.050 |
Why?
| Primates | 1 | 2022 | 114 | 0.050 |
Why?
| Myelopoiesis | 1 | 2020 | 8 | 0.050 |
Why?
| Smad1 Protein | 1 | 2020 | 20 | 0.050 |
Why?
| Oligonucleotide Probes | 2 | 2015 | 53 | 0.050 |
Why?
| Diabetes Mellitus | 1 | 2009 | 942 | 0.050 |
Why?
| Cochlear Nucleus | 1 | 2000 | 5 | 0.050 |
Why?
| Bystander Effect | 1 | 2020 | 14 | 0.050 |
Why?
| DNA Replication Timing | 1 | 2020 | 1 | 0.050 |
Why?
| Gene Ontology | 1 | 2020 | 55 | 0.050 |
Why?
| Transposases | 1 | 2020 | 9 | 0.050 |
Why?
| DNA Footprinting | 1 | 2020 | 28 | 0.050 |
Why?
| Forkhead Transcription Factors | 1 | 2021 | 182 | 0.050 |
Why?
| CpG Islands | 2 | 2015 | 119 | 0.050 |
Why?
| Deoxyribonuclease I | 1 | 2020 | 36 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 154 | 0.050 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2000 | 50 | 0.050 |
Why?
| Cell Respiration | 1 | 2020 | 76 | 0.050 |
Why?
| Gene Expression Regulation, Viral | 1 | 2020 | 84 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 173 | 0.050 |
Why?
| Karyotype | 1 | 2019 | 12 | 0.050 |
Why?
| Static Electricity | 1 | 2020 | 121 | 0.050 |
Why?
| Potassium Channels | 1 | 2000 | 123 | 0.050 |
Why?
| Genetic Variation | 1 | 2005 | 926 | 0.040 |
Why?
| Interferons | 1 | 2020 | 151 | 0.040 |
Why?
| Karyotyping | 1 | 2019 | 102 | 0.040 |
Why?
| Blastocyst | 1 | 2019 | 44 | 0.040 |
Why?
| Molecular Dynamics Simulation | 1 | 2021 | 213 | 0.040 |
Why?
| Cell Movement | 2 | 2016 | 896 | 0.040 |
Why?
| Histocompatibility Antigens Class II | 1 | 2020 | 355 | 0.040 |
Why?
| Drug Delivery Systems | 1 | 2021 | 306 | 0.040 |
Why?
| Flow Cytometry | 2 | 2014 | 1085 | 0.040 |
Why?
| Interphase | 1 | 2018 | 30 | 0.040 |
Why?
| Inflammation | 1 | 2009 | 2566 | 0.040 |
Why?
| HL-60 Cells | 1 | 2018 | 29 | 0.040 |
Why?
| Internet | 1 | 2003 | 633 | 0.040 |
Why?
| Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 10 | 0.040 |
Why?
| Genes, Switch | 1 | 2018 | 7 | 0.040 |
Why?
| Regenerative Medicine | 1 | 2018 | 46 | 0.040 |
Why?
| Chromosome Deletion | 1 | 2018 | 95 | 0.040 |
Why?
| GATA4 Transcription Factor | 1 | 2018 | 18 | 0.040 |
Why?
| Biotinylation | 1 | 2017 | 31 | 0.040 |
Why?
| Antigens, CD | 1 | 2020 | 460 | 0.040 |
Why?
| Cytarabine | 1 | 2018 | 53 | 0.040 |
Why?
| A549 Cells | 1 | 2018 | 48 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2018 | 73 | 0.040 |
Why?
| Inhibitor of Differentiation Protein 2 | 1 | 2017 | 4 | 0.040 |
Why?
| STAT5 Transcription Factor | 1 | 2017 | 43 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2018 | 73 | 0.040 |
Why?
| Lymphocyte Subsets | 1 | 2017 | 76 | 0.040 |
Why?
| Oncogene Protein pp60(v-src) | 1 | 2016 | 5 | 0.040 |
Why?
| Pharmacogenetics | 1 | 2018 | 151 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2020 | 940 | 0.040 |
Why?
| Lipid Metabolism | 1 | 2020 | 477 | 0.040 |
Why?
| Myocytes, Cardiac | 1 | 2021 | 472 | 0.040 |
Why?
| Macaca | 1 | 2016 | 54 | 0.040 |
Why?
| Mice, Nude | 2 | 2010 | 663 | 0.040 |
Why?
| Antigens, Ly | 1 | 2016 | 45 | 0.040 |
Why?
| MCF-7 Cells | 1 | 2016 | 111 | 0.040 |
Why?
| Spleen | 1 | 2018 | 510 | 0.040 |
Why?
| Mammary Glands, Human | 1 | 2016 | 61 | 0.040 |
Why?
| Phosphorylation | 1 | 2021 | 1633 | 0.040 |
Why?
| Immunogenetic Phenomena | 1 | 2016 | 6 | 0.040 |
Why?
| Cell Fractionation | 1 | 2016 | 53 | 0.040 |
Why?
| Lipids | 1 | 2020 | 607 | 0.030 |
Why?
| Carrier Proteins | 1 | 2020 | 726 | 0.030 |
Why?
| RNA Polymerase III | 1 | 2016 | 25 | 0.030 |
Why?
| Biopsy | 1 | 2019 | 1079 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2010 | 1206 | 0.030 |
Why?
| Mice, Inbred NOD | 2 | 2008 | 574 | 0.030 |
Why?
| Heterochromatin | 1 | 2015 | 38 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 198 | 0.030 |
Why?
| Transduction, Genetic | 1 | 2015 | 116 | 0.030 |
Why?
| Transcriptional Activation | 2 | 2010 | 348 | 0.030 |
Why?
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| Proteomics | 1 | 2021 | 876 | 0.030 |
Why?
| Models, Molecular | 1 | 2020 | 1435 | 0.030 |
Why?
| Blood | 1 | 2015 | 100 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2015 | 105 | 0.030 |
Why?
| Genes, Suppressor | 1 | 2014 | 4 | 0.030 |
Why?
| Corpus Callosum | 1 | 2014 | 57 | 0.030 |
Why?
| Energy Metabolism | 1 | 2020 | 767 | 0.030 |
Why?
| Protein Isoforms | 1 | 2016 | 345 | 0.030 |
Why?
| Coculture Techniques | 1 | 2015 | 208 | 0.030 |
Why?
| Killer Cells, Natural | 1 | 2017 | 381 | 0.030 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 210 | 0.030 |
Why?
| Transfection | 1 | 2016 | 888 | 0.030 |
Why?
| Catalytic Domain | 1 | 2015 | 206 | 0.030 |
Why?
| Eosinophils | 1 | 2016 | 282 | 0.030 |
Why?
| Precipitin Tests | 2 | 2004 | 93 | 0.030 |
Why?
| Membrane Transport Proteins | 1 | 2015 | 137 | 0.030 |
Why?
| Nucleosomes | 1 | 2015 | 131 | 0.030 |
Why?
| RNA Editing | 1 | 2014 | 22 | 0.030 |
Why?
| Autoimmunity | 1 | 2020 | 831 | 0.030 |
Why?
| Virus Replication | 1 | 2016 | 405 | 0.030 |
Why?
| Computer Simulation | 1 | 2018 | 922 | 0.030 |
Why?
| Cell Death | 1 | 2015 | 339 | 0.030 |
Why?
| RNA Isoforms | 1 | 2013 | 1 | 0.030 |
Why?
| Neurogenesis | 1 | 2014 | 105 | 0.030 |
Why?
| HapMap Project | 1 | 2013 | 3 | 0.030 |
Why?
| Ataxins | 1 | 2013 | 3 | 0.030 |
Why?
| Toll-Like Receptor 5 | 1 | 2013 | 15 | 0.030 |
Why?
| Ataxin-1 | 1 | 2013 | 4 | 0.030 |
Why?
| RNA Cap-Binding Proteins | 1 | 2013 | 4 | 0.030 |
Why?
| Lung | 2 | 2018 | 3664 | 0.030 |
Why?
| ELAV Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| Flagellin | 1 | 2013 | 15 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 1194 | 0.030 |
Why?
| Chemokine CXCL12 | 1 | 2013 | 80 | 0.030 |
Why?
| Cell Cycle | 1 | 2016 | 550 | 0.030 |
Why?
| Substrate Specificity | 1 | 2013 | 371 | 0.030 |
Why?
| NIH 3T3 Cells | 1 | 2013 | 139 | 0.030 |
Why?
| Cytokines | 1 | 2020 | 1900 | 0.030 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 289 | 0.030 |
Why?
| Acetylation | 1 | 2013 | 217 | 0.030 |
Why?
| Multigene Family | 1 | 2013 | 200 | 0.030 |
Why?
| Codon | 1 | 2012 | 89 | 0.030 |
Why?
| Tretinoin | 1 | 2013 | 116 | 0.030 |
Why?
| History, 21st Century | 1 | 2013 | 170 | 0.030 |
Why?
| RNA Folding | 1 | 2012 | 32 | 0.030 |
Why?
| History, 20th Century | 1 | 2013 | 281 | 0.030 |
Why?
| Genetic Research | 1 | 2011 | 19 | 0.030 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 35 | 0.030 |
Why?
| 3T3 Cells | 1 | 2012 | 141 | 0.030 |
Why?
| Adipose Tissue, White | 1 | 2012 | 35 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2020 | 2275 | 0.030 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2012 | 39 | 0.030 |
Why?
| Expressed Sequence Tags | 1 | 2011 | 38 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2013 | 148 | 0.030 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 237 | 0.030 |
Why?
| Cellular Senescence | 1 | 2013 | 151 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2012 | 194 | 0.030 |
Why?
| Data Mining | 1 | 2012 | 113 | 0.030 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2013 | 298 | 0.020 |
Why?
| Adipose Tissue, Brown | 1 | 2012 | 71 | 0.020 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 195 | 0.020 |
Why?
| Skin Diseases | 1 | 2012 | 125 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 341 | 0.020 |
Why?
| Neutrophils | 1 | 2016 | 1233 | 0.020 |
Why?
| PPAR gamma | 1 | 2012 | 188 | 0.020 |
Why?
| Zygote | 1 | 2010 | 17 | 0.020 |
Why?
| Gene Dosage | 1 | 2011 | 136 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3588 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2013 | 462 | 0.020 |
Why?
| Lipopeptides | 1 | 2009 | 16 | 0.020 |
Why?
| Bias | 1 | 2011 | 198 | 0.020 |
Why?
| Career Choice | 1 | 2011 | 192 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 245 | 0.020 |
Why?
| Poly I-C | 1 | 2009 | 55 | 0.020 |
Why?
| Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| Feedback, Physiological | 1 | 2009 | 75 | 0.020 |
Why?
| Mice, SCID | 1 | 2010 | 333 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 280 | 0.020 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2009 | 49 | 0.020 |
Why?
| Toll-Like Receptors | 1 | 2009 | 167 | 0.020 |
Why?
| Random Allocation | 1 | 2009 | 344 | 0.020 |
Why?
| Lacrimal Apparatus | 1 | 2008 | 11 | 0.020 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 103 | 0.020 |
Why?
| Models, Animal | 1 | 2010 | 363 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2009 | 114 | 0.020 |
Why?
| Vacuoles | 1 | 2008 | 33 | 0.020 |
Why?
| Polyribosomes | 1 | 2008 | 23 | 0.020 |
Why?
| Salivary Glands | 1 | 2008 | 32 | 0.020 |
Why?
| Secretory Vesicles | 1 | 2008 | 24 | 0.020 |
Why?
| Oxidoreductases, N-Demethylating | 1 | 2007 | 9 | 0.020 |
Why?
| Leukocytes | 1 | 2009 | 290 | 0.020 |
Why?
| Macromolecular Substances | 1 | 2008 | 201 | 0.020 |
Why?
| Eye | 1 | 2008 | 106 | 0.020 |
Why?
| Oncogene Proteins, Fusion | 1 | 2009 | 181 | 0.020 |
Why?
| Adenosine Triphosphatases | 1 | 2008 | 158 | 0.020 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 59 | 0.020 |
Why?
| Embryo, Nonmammalian | 1 | 2007 | 176 | 0.020 |
Why?
| DNA Primers | 1 | 2008 | 533 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 1720 | 0.020 |
Why?
| Uveitis | 1 | 2006 | 116 | 0.020 |
Why?
| Actins | 1 | 2008 | 404 | 0.020 |
Why?
| Glucose | 1 | 2010 | 953 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2004 | 193 | 0.020 |
Why?
| Colforsin | 1 | 2004 | 55 | 0.020 |
Why?
| Transcription Factor RelA | 1 | 2003 | 82 | 0.010 |
Why?
| Quality Improvement | 1 | 2011 | 963 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2490 | 0.010 |
Why?
| Prognosis | 1 | 2010 | 3443 | 0.010 |
Why?
| Shal Potassium Channels | 1 | 2000 | 6 | 0.010 |
Why?
| Blood Glucose | 1 | 2010 | 1939 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 2000 | 59 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2003 | 1308 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 311 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2003 | 1171 | 0.010 |
Why?
| Middle Aged | 1 | 2010 | 27617 | 0.010 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|